424980 — Micro2nano Balance Sheet
0.000.00%
- KR₩50bn
- KR₩46bn
- KR₩10bn
- 25
- 21
- 49
- 18
Annual balance sheet for Micro2nano, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10,434 | 12,944 | 22,678 | 23,716 | 19,331 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,764 | 4,779 | 908 | 4,028 | 2,522 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 15,071 | 24,478 | 30,046 | 31,474 | 28,465 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17,704 | 16,789 | 16,440 | 16,962 | 16,556 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 36,603 | 45,200 | 49,452 | 53,509 | 52,739 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,675 | 7,384 | 7,112 | 7,284 | 5,078 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 21,511 | 25,270 | 23,369 | 20,064 | 22,467 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 15,092 | 19,930 | 26,082 | 33,445 | 30,273 |
| Total Liabilities & Shareholders' Equity | 36,603 | 45,200 | 49,452 | 53,509 | 52,739 |
| Total Common Shares Outstanding |